# Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre

Study · id `cardio:ct-nct07687186` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07687186](<https://clinicaltrials.gov/study/NCT07687186>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07687186

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 636 participants.

## Technical summary

Registry record NCT07687186. Randomized; quadruple masking; primary purpose treatment. Start 2026-08-21 (actual); primary completion 2028-06-22 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 636 participants (planned count; ClinicalTrials.gov record NCT07687186, source copy `cardio:ctgov-nct07687186-2026-10-23`, retrieved 2026-10-26)
- Started: 2026-08-21 (actual) (ClinicalTrials.gov record NCT07687186, source copy `cardio:ctgov-nct07687186-2026-10-23`, retrieved 2026-10-26)
- Primary completion: 2028-06-22 (anticipated) (ClinicalTrials.gov record NCT07687186, source copy `cardio:ctgov-nct07687186-2026-10-23`, retrieved 2026-10-26)
- Completion: 2028-06-22 (anticipated) (ClinicalTrials.gov record NCT07687186, source copy `cardio:ctgov-nct07687186-2026-10-23`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07687186, source copy `cardio:ctgov-nct07687186-2026-10-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07687186-2026-10-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
- Condition: Heart Failure
- Intervention (Drug): Qishen Yiqi Dripping Pills 2 bags
- Intervention (Drug): Qishen Yiqi Dripping Pills placebo 2 bags
- Lead sponsor: Tasly Pharmaceutical Group Co., Ltd
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Tasly Pharmaceutical Group Co., Ltd (`cardio:org-tasly-pharmaceutical-group-co-ltd`)

## Provenance

Content hash: f33ae3d7680ae34ae94e0caab7bf5e6099e86f0f685e1cf575127e170a9b8b14
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
